Jubilant Ingrevia (BOM:543271) Marketable Securities: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543271 Jubilant Ingrevia Ltd BOM:543271
82 GF Score
Price ₹685.55
GF Value ₹757.27
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Jubilant Ingrevia Marketable Securities?

Jubilant Ingrevia BOM:543271 -0.54% 82 Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:543271 with a GF Score™ of 82/100 and a GF Value™ of ₹757.27 (Fairly Valued). The stock has 5 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Jubilant Ingrevia's Marketable Securities for the quarter that ended in Jun. 2026 was ₹0 Mil.

Jubilant Ingrevia's annual Marketable Securities increased from Mar. 2024 (₹41 Mil) to Mar. 2025 (₹200 Mil) but then declined from Mar. 2025 (₹200 Mil) to Mar. 2026 (₹71 Mil).


Jubilant Ingrevia  (BOM:543271) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Jubilant Ingrevia Marketable Securities Related Terms


Jubilant Ingrevia Marketable Securities Historical Data

* Premium members only.

The historical data trend for Jubilant Ingrevia's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jubilant Ingrevia Marketable Securities Chart

Jubilant Ingrevia Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial 188.59 125.02 40.52 200.37 70.62

Jubilant Ingrevia Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 685.60 0.00 70.62 0.00
BOM:543271
82GF Score
Jubilant Ingrevia Ltd BOM:543271
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jubilant Ingrevia Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0 Mil mean?
Jubilant Ingrevia (BOM:543271) has a Marketable Securities of ₹0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Jubilant Ingrevia and its competitors.
Is Jubilant Ingrevia's Marketable Securities too high?
Jubilant Ingrevia's current Marketable Securities is ₹0 Mil. Overall, Jubilant Ingrevia has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jubilant Ingrevia's Marketable Securities compare to LIN and SHW?
Jubilant Ingrevia's Marketable Securities of ₹0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Chemicals company?
A good Marketable Securities depends on the Chemicals industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Jubilant Ingrevia and its competitors. Jubilant Ingrevia's current Marketable Securities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jubilant Ingrevia stock overvalued right now?
Based on GuruFocus' analysis, Jubilant Ingrevia (BOM:543271) is currently considered Fairly Valued. The stock's GF Value™ is ₹757.27, compared to a current price of ₹685.55 — trading 9.5% below its estimated fair value. The current Marketable Securities is ₹0 Mil. Jubilant Ingrevia's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Jubilant Ingrevia (BOM:543271), the current Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jubilant Ingrevia (BOM:543271) Overvalued in 2026?

Based on GuruFocus' analysis, Jubilant Ingrevia stock appears to be undervalued. The current stock price of ₹685.55 is trading 9.5% below its estimated GF Value™ of ₹757.27. GuruFocus considers Jubilant Ingrevia to be Fairly Valued.

Key valuation signals for BOM:543271:

  • Marketable Securities: ₹0 Mil
  • GF Value™: ₹757.27 vs. price of ₹685.55 (9.5% below fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the BOM:543271 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jubilant Ingrevia Business Description

Other Exchanges JUBLINGREA:India
Address 1-A, Sector 16-A, Noida, UP, IND, 201301
Jubilant Ingrevia Ltd is a life science products and solutions provider in the chemicals industry. It serves Pharmaceutical, Nutrition, Agrochemical, Consumer, and Industrial customers with its customized products and solutions. Its segments are Specialty chemicals, Nutrition & Health solutions, and Chemical Intermediates. The maximum revenue for the company is generated from its Specialty chemicals segment, which includes Bio-Pyridine & Bio-Picolines, Fine chemicals, Agro chemicals, Custom development and manufacturing organization, Microbial control solutions.. Geographically, it derives key revenue from India and the rest from the Americas and Europe, China, and the Rest of the world.
82GF Score

Get the complete analysis for BOM:543271

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹685.55
Price
₹757.27
GF Value